• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Prognostic significance of the modified Barthel index in elderly patients with diffuse large B-cell lymphoma.

作者信息

Ogura Shinji, Nakazato Tomonori

机构信息

Department of Hematology, Yokohama Municipal Citizen's Hospital, 56 Okazawa-cho, Hodogaya-ku, Yokohama, Japan.

Department of Hematology, Yokohama Municipal Citizen's Hospital, 56 Okazawa-cho, Hodogaya-ku, Yokohama, Japan.

出版信息

Eur J Intern Med. 2020 May;75:110-111. doi: 10.1016/j.ejim.2020.01.021. Epub 2020 Feb 8.

DOI:10.1016/j.ejim.2020.01.021
PMID:32044179
Abstract
摘要

相似文献

1
Prognostic significance of the modified Barthel index in elderly patients with diffuse large B-cell lymphoma.改良巴氏指数在老年弥漫性大B细胞淋巴瘤患者中的预后意义
Eur J Intern Med. 2020 May;75:110-111. doi: 10.1016/j.ejim.2020.01.021. Epub 2020 Feb 8.
2
Doxorubicin-based chemotherapy for diffuse large B-cell lymphoma in elderly patients: comparison of treatment outcomes between young and elderly patients and the significance of doxorubicin dosage.老年弥漫性大B细胞淋巴瘤患者基于多柔比星的化疗：年轻与老年患者治疗结果比较及多柔比星剂量的意义
Cancer. 2003 Dec 15;98(12):2651-6. doi: 10.1002/cncr.11846.
3
Prognostic effect of Ki-67 expression in rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone-treated diffuse large B-cell lymphoma is limited to non-germinal center B-cell-like subtype in late-elderly patients.在接受利妥昔单抗、环磷酰胺、阿霉素、长春新碱和泼尼松治疗的弥漫性大B细胞淋巴瘤中，Ki-67表达的预后影响仅限于老年晚期患者的非生发中心B细胞样亚型。
Leuk Lymphoma. 2015;56(9):2630-6. doi: 10.3109/10428194.2015.1004169. Epub 2015 Feb 4.
4
Immunochemotherapy is the standard of care in elderly patients with diffuse large B-cell lymphoma.免疫化疗是老年弥漫性大B细胞淋巴瘤患者的标准治疗方法。
Blood. 2004 Sep 1;104(5):1584-5; author reply 1585-6. doi: 10.1182/blood-2004-04-1266.
5
Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte.R-CHOP方案治疗老年弥漫性大B细胞淋巴瘤的长期结果：成人淋巴瘤研究组的一项研究
J Clin Oncol. 2005 Jun 20;23(18):4117-26. doi: 10.1200/JCO.2005.09.131. Epub 2005 May 2.
6
High-risk diffuse large B-cell lymphoma: can we do better than rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone?高危弥漫性大B细胞淋巴瘤：我们能否比利妥昔单抗、环磷酰胺、阿霉素、长春新碱和泼尼松做得更好？
Leuk Lymphoma. 2013 Dec;54(12):2575-6. doi: 10.3109/10428194.2013.796059. Epub 2013 May 21.
7
Prognostic impact of sarcopenia in patients with diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone.利妥昔单抗联合环磷酰胺、多柔比星、长春新碱和泼尼松治疗弥漫性大 B 细胞淋巴瘤患者中肌肉减少症的预后影响。
J Cachexia Sarcopenia Muscle. 2016 Dec;7(5):567-576. doi: 10.1002/jcsm.12115. Epub 2016 Apr 12.
8
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.老年弥漫性大B细胞淋巴瘤患者中，CHOP化疗联合利妥昔单抗与单纯CHOP化疗的比较。
N Engl J Med. 2002 Jan 24;346(4):235-42. doi: 10.1056/NEJMoa011795.
9
Pegylated liposomal doxorubicin replacing conventional doxorubicin in standard R-CHOP chemotherapy for elderly patients with diffuse large B-cell lymphoma: an open label, single arm, phase II trial.聚乙二醇化脂质体阿霉素在老年弥漫性大B细胞淋巴瘤患者标准R-CHOP化疗中替代传统阿霉素的开放标签、单臂、II期试验。
Clin Lymphoma Myeloma Leuk. 2015 Mar;15(3):152-8. doi: 10.1016/j.clml.2014.09.001. Epub 2014 Sep 28.
10
The impacts of initial and relative dose intensity of R-CHOP on outcomes of elderly patients with diffuse large B-cell lymphoma.R-CHOP方案的初始剂量强度和相对剂量强度对老年弥漫性大B细胞淋巴瘤患者预后的影响。
Leuk Lymphoma. 2017 Mar;58(3):736-739. doi: 10.1080/10428194.2016.1211279. Epub 2016 Aug 11.

引用本文的文献

1
Validation and modification of simplified Geriatric Assessment and Elderly Prognostic Index: Effective tools for older patients with diffuse large B-cell lymphoma.简化版老年评估和老年预后指数的验证和修改：弥漫性大 B 细胞淋巴瘤老年患者的有效工具。
Cancer Med. 2024 Jan;13(1):e6856. doi: 10.1002/cam4.6856. Epub 2023 Dec 22.
2
Clinical Utility of the Geriatric Nutritional Risk Index Before Surgical Intervention for Epithelial Ovarian Cancer Patients: A Retrospective Study.老年营养风险指数在上皮性卵巢癌患者手术干预前的临床应用：一项回顾性研究
J Clin Med Res. 2022 Oct;14(10):409-415. doi: 10.14740/jocmr4816. Epub 2022 Oct 28.